These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22234302)

  • 1. Temperature profoundly affects ataxin-3 fibrillogenesis.
    Apicella A; Natalello A; Frana AM; Baserga A; Casari CS; Bottani CE; Doglia SM; Tortora P; Regonesi ME
    Biochimie; 2012 Apr; 94(4):1026-31. PubMed ID: 22234302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A major role for side-chain polyglutamine hydrogen bonding in irreversible ataxin-3 aggregation.
    Natalello A; Frana AM; Relini A; Apicella A; Invernizzi G; Casari C; Gliozzi A; Doglia SM; Tortora P; Regonesi ME
    PLoS One; 2011 Apr; 6(4):e18789. PubMed ID: 21533208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigallocatechin-3-gallate and tetracycline differently affect ataxin-3 fibrillogenesis and reduce toxicity in spinocerebellar ataxia type 3 model.
    Bonanomi M; Natalello A; Visentin C; Pastori V; Penco A; Cornelli G; Colombo G; Malabarba MG; Doglia SM; Relini A; Regonesi ME; Tortora P
    Hum Mol Genet; 2014 Dec; 23(24):6542-52. PubMed ID: 25030034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis.
    Ricchelli F; Fusi P; Tortora P; Valtorta M; Riva M; Tognon G; Chieregato K; Bolognin S; Zatta P
    Int J Biochem Cell Biol; 2007; 39(5):966-77. PubMed ID: 17300980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the central flexible region on the aggregation and conformational properties of human ataxin-3.
    Santambrogio C; Frana AM; Natalello A; Papaleo E; Regonesi ME; Doglia SM; Tortora P; Invernizzi G; Grandori R
    FEBS J; 2012 Feb; 279(3):451-63. PubMed ID: 22129356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between aggregation and toxicity of polyglutamine-containing ataxin-3 in the intracellular environment of Escherichia coli.
    Invernizzi G; Aprile FA; Natalello A; Ghisleni A; Penco A; Relini A; Doglia SM; Tortora P; Regonesi ME
    PLoS One; 2012; 7(12):e51890. PubMed ID: 23251648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Josephin domain determines the morphological and mechanical properties of ataxin-3 fibrils.
    Masino L; Nicastro G; De Simone A; Calder L; Molloy J; Pastore A
    Biophys J; 2011 Apr; 100(8):2033-42. PubMed ID: 21504740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step.
    Ellisdon AM; Thomas B; Bottomley SP
    J Biol Chem; 2006 Jun; 281(25):16888-16896. PubMed ID: 16624810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel beta -fibrils.
    Bevivino AE; Loll PJ
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):11955-60. PubMed ID: 11572942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
    Haacke A; Broadley SA; Boteva R; Tzvetkov N; Hartl FU; Breuer P
    Hum Mol Genet; 2006 Feb; 15(4):555-68. PubMed ID: 16407371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome.
    Bonanomi M; Mazzucchelli S; D'Urzo A; Nardini M; Konarev PV; Invernizzi G; Svergun DI; Vanoni M; Regonesi ME; Tortora P
    Int J Biochem Cell Biol; 2014 Jun; 51():58-64. PubMed ID: 24685680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature-dependent, irreversible formation of amyloid fibrils by a soluble human ataxin-3 carrying a moderately expanded polyglutamine stretch (Q36).
    Shehi E; Fusi P; Secundo F; Pozzuolo S; Bairati A; Tortora P
    Biochemistry; 2003 Dec; 42(49):14626-32. PubMed ID: 14661975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: removal of the CAG containing exon.
    Evers MM; Tran HD; Zalachoras I; Pepers BA; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Neurobiol Dis; 2013 Oct; 58():49-56. PubMed ID: 23659897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Epigallocatechin-3-gallate and Tetracycline Interact with the Josephin Domain of Ataxin-3 and Alter Its Aggregation Mode.
    Bonanomi M; Visentin C; Natalello A; Spinelli M; Vanoni M; Airoldi C; Regonesi ME; Tortora P
    Chemistry; 2015 Dec; 21(50):18383-93. PubMed ID: 26538519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3.
    Gales L; Cortes L; Almeida C; Melo CV; Costa MC; Maciel P; Clarke DT; Damas AM; Macedo-Ribeiro S
    J Mol Biol; 2005 Oct; 353(3):642-54. PubMed ID: 16194547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3.
    Mueller T; Breuer P; Schmitt I; Walter J; Evert BO; Wüllner U
    Hum Mol Genet; 2009 Sep; 18(17):3334-43. PubMed ID: 19542537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
    Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
    J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.
    Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the Josephin Domain protein-protein interaction by molecular dynamics.
    Deriu MA; Grasso G; Licandro G; Danani A; Gallo D; Tuszynski JA; Morbiducci U
    PLoS One; 2014; 9(9):e108677. PubMed ID: 25268243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
    Matos CA; de Macedo-Ribeiro S; Carvalho AL
    Prog Neurobiol; 2011 Sep; 95(1):26-48. PubMed ID: 21740957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.